TY - JOUR
T1 - A hooded exposure chamber method for semiquantitative latex aeroallergen challenge
AU - Kurtz, Kenneth M.
AU - Hamilton, Robert G.
AU - Schaefer, John A.
AU - Adkinson, N. Franklin
N1 - Funding Information:
From athe Department of Medicine, Division of Allergy & Clinical Immunol-ogy at the Johns Hopkins Asthma and Allergy Center, Baltimore; and bOc-cupational Health and Safety, Johns Hopkins University, Baltimore. Supported by National Institutes of Health grants AI43654 and AI31867 and a Glaxo Wellcome Allergy Fellowship Research Award to Dr Kurtz. Received for publication May 5, 2000; revised September 12, 2000; accepted for publication October 5, 2000. Reprint requests: N. Franklin Adkinson, Jr, MD, Professor of Medicine, Johns Hopkins Asthma & Allergy Center, 5501 Hopkins Bayview Circle, Room 2A62, Baltimore, MD 21224. Copyright © 2001 by Mosby, Inc. 0091-6749/2001 $35.00 + 0 1/86/112125 doi:10.1067/mai.2001.112125
PY - 2001/1
Y1 - 2001/1
N2 - Background: Allergen challenges are useful in adjudicating discordant clinical histories and skin test responses, serologic test responses, or both, as well as in determining the degree of allergic reactivity. Latex allergen challenges have been developed but have limitations that reduce their usefulness. Objective: We sought to develop a novel hooded exposure chamber (HEC) system to allow safe, sensitive, and semiquantitative evaluation of respiratory latex allergy. Methods: The HEC system uses an impinger to produce a particle cloud of cornstarch isolated from powdered latex gloves. The particles are air driven into a face shield and hood to simultaneously challenge the subject's conjunctiva, nose, and lungs during 3 minutes of normal tidal breathing. A cloud of respirable latex allergen-associated cornstarch particles (LACs) is consistently produced in the HEC during challenges. Twenty-three subjects with latex allergy (history and positive skin test response, positive serologic test response, or both) and 3 atopic control subjects not allergic to latex (history and negative skin test response, negative serologic test response, or both) were sequentially exposed to air, control cornstarch, and then progressive 2-fold increments of LACs in a single-masked fashion. A positive challenge result was defined us (1) a peak expiratory flow rate decline of 15% or greater from baseline; (2) a peak expiratory flow rate decline of 10% or greater and an increase of either the rhinoconjunctivitis or chest symptom score scale of 3 or more points from baseline; or (3) an increase of either the rhinoconjunctivitis or chest symptom score scale of 6 or more points from baseline. Results: Twenty-two of the 23 subjects with latex allergy reached threshold criteria for a positive challenge at LAC titers of 1:8 or greater, giving a sensitivity of 0.96. Challenge endpoints were moderately corrected with skin test sensitivity (rs = -0.55, P = .O1) but not with RAST reactivity. None of the 3 control subjects responded to LACs at the 1:8 dilution. No patient or control subject responded to the air or control cornstarch control exposures. All responses were confined to mild symptoms of allergic rhinoconjunctivitis, asthma, or both that either resolved spontaneously or were easily reversed with inhaled albuterol. No subject experienced a systemic or late-phase reaction. Conclusion: The HEC procedure is a safe, sensitive, and specific method for masked semiquantitative latex aeroallergen challenges that mimic occupational latex exposure to powdered latex gloves.
AB - Background: Allergen challenges are useful in adjudicating discordant clinical histories and skin test responses, serologic test responses, or both, as well as in determining the degree of allergic reactivity. Latex allergen challenges have been developed but have limitations that reduce their usefulness. Objective: We sought to develop a novel hooded exposure chamber (HEC) system to allow safe, sensitive, and semiquantitative evaluation of respiratory latex allergy. Methods: The HEC system uses an impinger to produce a particle cloud of cornstarch isolated from powdered latex gloves. The particles are air driven into a face shield and hood to simultaneously challenge the subject's conjunctiva, nose, and lungs during 3 minutes of normal tidal breathing. A cloud of respirable latex allergen-associated cornstarch particles (LACs) is consistently produced in the HEC during challenges. Twenty-three subjects with latex allergy (history and positive skin test response, positive serologic test response, or both) and 3 atopic control subjects not allergic to latex (history and negative skin test response, negative serologic test response, or both) were sequentially exposed to air, control cornstarch, and then progressive 2-fold increments of LACs in a single-masked fashion. A positive challenge result was defined us (1) a peak expiratory flow rate decline of 15% or greater from baseline; (2) a peak expiratory flow rate decline of 10% or greater and an increase of either the rhinoconjunctivitis or chest symptom score scale of 3 or more points from baseline; or (3) an increase of either the rhinoconjunctivitis or chest symptom score scale of 6 or more points from baseline. Results: Twenty-two of the 23 subjects with latex allergy reached threshold criteria for a positive challenge at LAC titers of 1:8 or greater, giving a sensitivity of 0.96. Challenge endpoints were moderately corrected with skin test sensitivity (rs = -0.55, P = .O1) but not with RAST reactivity. None of the 3 control subjects responded to LACs at the 1:8 dilution. No patient or control subject responded to the air or control cornstarch control exposures. All responses were confined to mild symptoms of allergic rhinoconjunctivitis, asthma, or both that either resolved spontaneously or were easily reversed with inhaled albuterol. No subject experienced a systemic or late-phase reaction. Conclusion: The HEC procedure is a safe, sensitive, and specific method for masked semiquantitative latex aeroallergen challenges that mimic occupational latex exposure to powdered latex gloves.
KW - Aeroallergen challenge
KW - Latex allergy
KW - Occupational allergy
KW - Occupational asthma
UR - http://www.scopus.com/inward/record.url?scp=0035143254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035143254&partnerID=8YFLogxK
U2 - 10.1067/mai.2001.112125
DO - 10.1067/mai.2001.112125
M3 - Article
C2 - 11150009
AN - SCOPUS:0035143254
SN - 0091-6749
VL - 107
SP - 178
EP - 184
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -